Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

End-stage reflux nephropathy

R R Bailey1, K L Lynn, R A Robson

  • 1Department of Nephrology, Christchurch Hospital, New Zealand.

Renal Failure
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myocardial metastasis of cutaneous squamous cell carcinoma in a renal transplant recipient.

Transplantation proceedings·2009
Same author

Diagnosis of aspergillus peritonitis in a renal dialysis patient by PCR and galactomannan detection.

Journal of clinical pathology·2004
Same author

A combination study design to examine mycophenolate mofetil (MMF) and PTLD in renal transplant patients.

Pharmacoepidemiology and drug safety·2004
Same author

Successful treatment of CAPD peritonitis caused by rhodotorula mucilaginosa.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2002
Same author

Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria.

Clinical nephrology·2001
Same author

Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio.

Clinical nephrology·2001
Same journal

Hypoxia-inducible factor-1α promotes epithelial-to-mesenchymal transition through upregulating cathepsin S expression in diabetic kidney disease.

Renal failure·2026
Same journal

Development and validation of a dual-channel deep learning for continuous acute kidney injury prediction in critically ill patients.

Renal failure·2026
Same journal

Relaxin inhibits renal interstitial fibrosis and promotes fatty acid metabolism after UUO <i>via</i> the AMPK/PGC1α signaling pathway.

Renal failure·2026
Same journal

A physiology-informed microRNA framework for urothelial carcinoma in hemodialysis patients.

Renal failure·2026
Same journal

Regulatory effects of leflunomide on gut microecology during IgA nephropathy treatment.

Renal failure·2026
Same journal

Inotodiol ameliorates oxidative stress and apoptosis by regulating PI3K/Akt/GSK-3β signaling pathways in diabetic nephropathy.

Renal failure·2026
See all related articles

Reflux nephropathy is a significant cause of end-stage renal failure, especially in young individuals. Early exclusion is crucial for patients with renal insufficiency, proteinuria, or hypertension, even without urinary tract infections.

Area of Science:

  • Nephrology
  • Urology
  • Transplantation

Background:

  • Reflux nephropathy is a recognized cause of end-stage renal disease (ESRD).
  • Its prevalence and clinical presentation in patients entering dialysis-transplant programs require further elucidation.
  • Understanding risk factors and diagnostic indicators is vital for timely intervention.

Purpose of the Study:

  • To determine the incidence of reflux nephropathy in patients referred for renal replacement therapy.
  • To characterize the clinical features and outcomes of patients with end-stage reflux nephropathy.
  • To assess the role of urinary tract infections, hypertension, and proteinuria in the presentation of reflux nephropathy.

Main Methods:

  • Retrospective analysis of 371 patients entering a dialysis-transplant program.

Related Experiment Videos

  • Identification of patients diagnosed with reflux nephropathy.
  • Review of clinical data including age, renal function, blood pressure, proteinuria, and history of urinary tract infections.

    • Main Results:

    • 11.3% (42/371) of patients had end-stage reflux nephropathy.
    • 6 out of 13 pediatric patients (<16 years) had reflux nephropathy.
    • Most patients presented with severe renal impairment, hypertension (35/42), and proteinuria; UTIs were infrequent.
    • Hypertension was often undiagnosed prior to presentation (22/35).
    • 20 out of 29 surviving patients received functioning renal transplants.

    Conclusions:

    • Reflux nephropathy is a critical contributor to ESRD, particularly in younger populations.
    • Patients with renal insufficiency and proteinuria, irrespective of UTI or hypertension, should be evaluated for reflux nephropathy.
    • Early diagnosis and management are essential to improve outcomes and transplant success rates.